STOCK TITAN

Koru Med Sys - KRMD STOCK NEWS

Welcome to our dedicated page for Koru Med Sys news (Ticker: KRMD), a resource for investors and traders seeking the latest updates and insights on Koru Med Sys stock.

KORU Medical Systems Inc (KRMD) specializes in innovative subcutaneous infusion systems for critical therapies. This hub provides authorized updates about the company's medical device developments, regulatory milestones, and strategic initiatives.

Investors and healthcare professionals will find timely announcements including product launch details, financial disclosures, and manufacturing updates. Our curated collection ensures access to verified information about FREEDOM infusion systems and related technologies.

Key updates cover FDA clearances, partnership announcements, clinical application insights, and operational developments. All content maintains strict compliance with financial disclosure regulations and medical device reporting standards.

Bookmark this page for streamlined access to KRMD's latest advancements in immunoglobulin therapy delivery systems. Check regularly for official updates directly impacting the medical device sector and chronic care treatment landscapes.

Rhea-AI Summary
KORU Medical Systems, Inc. (NASDAQ: KRMD) announces a development agreement with a biopharmaceutical manufacturer to create a next-generation infusion system for subcutaneous immunoglobulin (SCIg) therapy, aiming to improve patient experience and facilitate easier home therapy. The collaboration reflects KORU Medical's commitment to providing innovative specialty subcutaneous infusion solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.31%
Tags
none
-
Rhea-AI Summary
KRMD: KORU Medical Systems, Inc. appoints Ken Miller as Chief Commercial Officer, bringing 30+ years of experience in healthcare. Miller's impressive track record includes a successful stint at NASCO Healthcare and Becton Dickinson, with notable achievements in sales & marketing and global expansion. As Chief Commercial Officer, Miller will oversee global sales and marketing, and his appointment comes with two separate options to purchase 200,000 shares of the Company's common stock. KORU Medical's President and CEO, Linda Tharby, expressed confidence in Miller's ability to drive the company's growth and success.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.31%
Tags
management
-
Rhea-AI Summary
KORU Medical Systems, Inc. (NASDAQ: KRMD) reported third quarter net revenue of $7.0 million, a 10% decline versus the prior year. The company also updated its full year 2023 outlook, revising net revenue guidance to $28.0 to $28.5 million and reaffirming gross margin guidance between 58%-60% for the full year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.31%
Tags
Rhea-AI Summary
KORU Medical Systems, Inc. (NASDAQ: KRMD) Receives FDA Clearance for FREEDOM60® Infusion System with Hizentra® 50 mL Prefilled Syringes, Expanding Benefits of SCIg Therapy in the Home
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.19%
Tags
-
Rhea-AI Summary
KORU Medical Systems (NASDAQ: KRMD) will participate in two upcoming investor conferences: Canaccord MedTech, Diagnostics and Digital Health & Services Forum and the 14th Annual Craig-Hallum Alpha Select Conference, both on November 16th, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.76%
Tags
conferences
-
Rhea-AI Summary
KORU Medical Systems will report its third quarter 2023 financial results on November 8, 2023. The company will host a conference call and webcast to discuss the results and provide a corporate update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.86%
Tags
conferences earnings
Rhea-AI Summary
KORU Medical Systems to present two abstracts at the Immunoglobulin National Society 2023 National Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
conferences
-
Rhea-AI Summary
KORU Medical Systems appoints Edward Wholihan to its Board of Directors, bringing over 25 years of experience as CFO in the life sciences and healthcare sectors. His insights are expected to contribute to the company's future growth and success.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
management
-
Rhea-AI Summary
KORU Medical Systems to participate in Gilmartin Group Emerging Growth Company Showcase on September 21, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
conferences acquisition
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.22%
Tags
Koru Med Sys

Nasdaq:KRMD

KRMD Rankings

KRMD Stock Data

104.74M
41.96M
7.12%
50.93%
1.11%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MAHWAH